CPRI
Capri Holdings Limited
CPRI has the edge over F overall, supported by stronger fundamentals and stronger modeled upside.
F
Ford Motor Company
F's outlook is improving, though it still trails on the overall score.
CPRI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
CPRI's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
CPRI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $14.12 | -31% |
| Forward | 9.4x | $20.38 | — |
| Current | 12x | $20.38 | — |
| Fair | 13x | $23.01 | +13% |
| Expensive | 21x | $36.91 | +81% |
Historical ranges are pointers, not guarantees.
CPRI's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 9.4x next year's earnings, in its cheap range.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
CPRI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect CPRI's earnings to grow and its profitability to improve, with its revenue holding steady.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect F's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CPRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.17 | +23% |
| Q3 2026 | $1.77 | +$11.64 |
| Q2 2026 | $1.30 | +$10.75 |
| Q1 2026 | $1.14 | +$11.14 |
| Q4 2025 | -$4.30 | +$4.24 |
| Q3 2025 | -$9.87 | -$6.82 |
| Q2 2025 | -$9.45 | -$6.97 |
| Q1 2025 | -$10.00 | -$8.04 |
| Q4 2024 | -$8.54 | -547% |
CPRI has the edge over F on earnings quality, reporting a profit while its opponent remains loss making.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
CPRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $809M | -5.5% |
| Q2 2026 | $769M | -3.5% |
| Q1 2026 | $796M | -23% |
| Q4 2025 | $1B | -19% |
| Q3 2025 | $856M | -21% |
| Q2 2025 | $797M | -25% |
| Q1 2025 | $1B | -15% |
| Q4 2024 | $1.3B | -12% |
CPRI's revenue has slid since its 2021 peak: $809M last quarter, down 5.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.2% | +2.6 points |
| Q2 2026 | 2.2% | +0.2 points |
| Q1 2026 | -3.4% | +7.8 points |
| Q4 2025 | 4.5% | +51 points |
| Q3 2025 | -1.4% | +2.1 points |
| Q2 2025 | 2% | +2.8 points |
| Q1 2025 | -11% | +33 points |
| Q4 2024 | -47% | -55 points |
CPRI's operating margin was 1.2% last quarter, up 2.6 points from the same quarter a year ago.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F has the edge over CPRI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F has the edge over CPRI on profitability, with a higher operating margin.
CPRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $36M | +$101M |
| Q2 2026 | $48M | +$69M |
| Q1 2026 | -$83M | +$105M |
| Q4 2025 | $183M | -34% |
| Q3 2025 | -$65M | -383% |
| Q2 2025 | -$21M | -153% |
| Q1 2025 | -$188M | -$182M |
| Q4 2024 | $278M | -11% |
CPRI still generates free cash flow, though less than at its 2022 peak: $184M over the past year.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F has the edge over CPRI on cash flow, with more consistent year-over-year improvement.
CPRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.9% | -5.7M shares |
| 1 year | -7.9% | -9.4M shares |
| 3 years | -6.1% | -7.2M shares |
| 5 years | -28% | -43.9M shares |
| Available history | -27% | -41.8M shares |
CPRI has the edge over F on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $150M |
| Q2 2026 | $54M |
| Q1 2026 | $79M |
| Q4 2025 | — |
| Q3 2025 | $1M |
| Q2 2025 | $1M |
| Q1 2025 | — |
| Q4 2024 | — |
CPRI spent $283M buying back its own shares over the past year, more than ten times what it spent the year before.
F Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +89M shares |
| 1 year | +0.7% | +28M shares |
| 3 years | +0.6% | +26M shares |
| 5 years | +1% | +40M shares |
| Available history | +1.8% | +72M shares |
F has 4.1B diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $311M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $150M |
F spent $311M buying back its own shares over the past year, up 107% from the year before.
CPRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q4 2023 | 3.9x | Elevated |
| Q3 2023 | 3.6x | Elevated |
| Q2 2023 | 2.5x | Moderate |
| Q1 2023 | 1.9x | Healthy |
CPRI's net debt is about 2.1 years of its operating earnings (EBITDA), down from 3.9 years a year ago.
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has the edge over CPRI on leverage, with a lower net debt burden relative to earnings.
CPRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.5 | Neutral |
| Stochastic | 88.5 | Overbought |
CPRI's weekly RSI is 64 (neutral) and its Stochastic is 88 (overbought).
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
CPRI PE vs Consumer Cyclical Sector
| Metric | CPRI | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 36% below |
| PE % | 43 | 47 | 4 pts below |
CPRI is trading at 12x earnings, a 36% discount to the Consumer Cyclical sector's median of 18x.
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
CPRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.0 | 20% above |
| 20 week MA | $16.0 | 27% above |
| 50 week MA | $19.1 | 6.9% above |
| 100 week MA | $19.5 | 4.5% above |
| 200 week MA | $30.6 | 33% below |
CPRI has the edge over F on trend strength, trading above more of its moving averages.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
CPRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.5 | $42.4 | +13% |
| 2021 | $42.4 | $61.7 | +45% |
| 2022 | $61.7 | $55.7 | -9.7% |
| 2023 | $55.7 | $50.2 | -9.8% |
| 2024 | $50.2 | $21.0 | -58% |
| 2025 | $21.0 | $25.0 | +19% |
| 2026 YTD | $25.0 | $20.4 | -18% |
CPRI has finished lower in three of the last six years. It's down 18% so far in 2026.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F has the edge over CPRI on returns for 2026, with the stronger performance.